PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Return
26.45%
This Quarter Return
-7.37%
1 Year Return
+26.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$88B
AUM Growth
-$12.1B
(-12%)
Cap. Flow
-$2.41B
Cap. Flow
% of AUM
-2.74%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
1,771
New
60
Increased
704
Reduced
423
Closed
94
Top Buys
| 1 |
Salesforce
CRM
|
$281M |
| 2 |
Waste Management
WM
|
$165M |
| 3 |
Tesla
TSLA
|
$164M |
| 4 |
Advanced Micro Devices
AMD
|
$164M |
| 5 |
Gen Digital
GEN
|
$132M |
Top Sells
| 1 |
Autodesk
ADSK
|
$331M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$329M |
| 3 |
NXP Semiconductors
NXPI
|
$295M |
| 4 |
Apple
AAPL
|
$284M |
| 5 |
Baidu
BIDU
|
$261M |
Sector Composition
| 1 | Technology | 27.87% |
| 2 | Healthcare | 15.14% |
| 3 | Industrials | 14.16% |
| 4 | Utilities | 9.85% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Align Technology
ALGN
$9.94B
| $76M | 0.09% |
174,323
-31,003
| -15% | -$13.5M |
|
252
Brown-Forman Class B
BF.B
$13B
| $75.9M | 0.09% |
1,132,001
-405,942
| -26% | -$27.2M |
|
253
Neurocrine Biosciences
NBIX
$14.3B
| $72.7M | 0.08% |
775,375
+363,942
| +88% | +$34.1M |
|
254
Alibaba
BABA
$334B
| $72.6M | 0.08% |
667,035
+102,982
| +18% | +$11.2M |
|
255
Scotiabank
BNS
$79.1B
| $72.3M | 0.08% |
1,008,537
-16,910
| -2% | -$1.21M |
|
256
Morgan Stanley
MS
$236B
| $72.3M | 0.08% |
827,151
-115,969
| -12% | -$10.1M |
|
257
Philip Morris
PM
$251B
| $72.1M | 0.08% |
767,746
-8,638
| -1% | -$811K |
|
258
Aflac
AFL
$56.7B
| $71.6M | 0.08% |
1,112,742
-420,456
| -27% | -$27.1M |
|
259
AT&T
T
$207B
| $71.2M | 0.08% |
3,987,427
-11,698,435
| -75% | -$209M |
|
260
Ventas
VTR
$30.8B
| $71M | 0.08% |
1,149,591
+82,282
| +8% | +$5.08M |
|
261
Airbnb
ABNB
$76.4B
| $70.6M | 0.08% |
411,306
+167,062
| +68% | +$28.7M |
|
262
Duke Energy
DUK
$93.4B
| $70.3M | 0.08% |
629,996
-12,034
| -2% | -$1.34M |
|
263
IBM
IBM
$237B
| $69.2M | 0.08% |
532,556
+13,120
| +3% | +$1.71M |
|
264
ConocoPhillips
COP
$113B
| $69.2M | 0.08% |
691,557
-7,125
| -1% | -$713K |
|
265
Teladoc Health
TDOC
$1.39B
| $69.1M | 0.08% |
958,066
+85,799
| +10% | +$6.19M |
|
266
Louisiana-Pacific
LPX
$6.9B
| $67.7M | 0.08% |
1,090,532
+79,139
| +8% | +$4.92M |
|
267
Constellation Energy
CEG
$93.6B
| $67.1M | 0.08% |
+1,192,329
| New | +$67.1M |
|
268
UDR
UDR
$12.8B
| $66.4M | 0.08% |
1,157,511
+111,283
| +11% | +$6.38M |
|
269
McCormick & Company Non-Voting
MKC
$18.8B
| $66.4M | 0.08% |
665,344
-311,531
| -32% | -$31.1M |
|
270
CME Group
CME
$94B
| $65.7M | 0.07% |
276,189
-37,428
| -12% | -$8.9M |
|
271
Honeywell
HON
$136B
| $65.4M | 0.07% |
336,353
+1,676
| +0.5% | +$326K |
|
272
Cognizant
CTSH
$34.8B
| $65M | 0.07% |
724,541
+4,985
| +0.7% | +$447K |
|
273
CoStar Group
CSGP
$37.5B
| $64.1M | 0.07% |
962,507
+11,226
| +1% | +$748K |
|
274
Marsh & McLennan
MMC
$99.6B
| $63.8M | 0.07% |
374,249
+26,664
| +8% | +$4.54M |
|
275
Charles Schwab
SCHW
$170B
| $63.4M | 0.07% |
752,246
+23,892
| +3% | +$2.01M |
|